CVS Health Corp (CVS) is trading at $94.99 up 0.29% over the past 24 hours. Its Galaxy Score is 60.4, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 9M engagements and 3.7K posts with 72% positive social sentiment.
AI summary: CVS Health (CVS) is at the center of mixed social and market signals as a Lilly partnership drives optimism while PBM pricing scrutiny and recalls inject volatility. The stock trades in the mid-$90s with potential for upside on regulatory developments or Lilly-driven catalysts, but gains are tempered by ongoing concerns. Social metrics show elevated engagement and a broad creator base, yet sentiment remains mixed given near-term headlines. Upside is buoyed by the Lilly deal and potential expanded GLP-1 access, but gains are capped by PBM pricing scrutiny and recall headlines; a clear regulatory or Lilly-specific catalyst could spark a breakout, otherwise expect choppy trading around the mid-$90s.
CVS Health Corp (CVS) is tracked on LunarCrush, where you can follow its price alongside live social activity and sentiment across X, Reddit, YouTube and other networks.
CVS Health Corp (CVS) is trading at $94.99, up 0.29% over the past 24 hours.
$CVS has a Galaxy Score of 60.4 — LunarCrush's 0–100 measure combining an asset's market and social performance.
Yes. $CVS social sentiment is 72% positive across social posts over the last 24 hours.
There have been 3.7K posts about $CVS over the last 24 hours.
On LunarCrush — follow $CVS's real-time social sentiment, engagement and market activity across X, Reddit, YouTube, TikTok and news in one place.